Manipal Health Enterprises Ltd

Manipal Health Enterprises Limited (Manipal Hospitals) has fully redeemed its outstanding listed non-convertible debentures (NCDs) worth ₹5,310 crore. The redemption utilized a portion of the proceeds from its Initial Public Offering (IPO). This move is a significant step in the company's post-listing financial strategy, aimed at strengthening its balance sheet, reducing interest burden, and improving financial leverage. The company also reported strong Q1 FY27 performance with revenue up 38.1% YoY to ₹3,091 crore and EBITDA up 26.4% to ₹749 crore. This proactive debt management is expected to provide greater financial flexibility for future growth and investment priorities.

Manipal Health Enterprises Ltd has utilized a portion of its Initial Public Offering (IPO) proceeds for the full redemption of outstanding listed non-convertible debentures. These debentures, issued by its wholly owned subsidiary Manipal Hospitals Private Limited, had a nominal value of ₹5,310 crores. The redemption included accrued interest and applicable prepayment/early redemption costs, aligning with the IPO's stated objectives as per the prospectus dated July 31, 2026. This action signifies the effective deployment of IPO funds towards debt reduction.

Manipal Health Enterprises Ltd. is communicating to shareholders regarding the 16th Annual General Meeting (AGM) and the Annual Report for the financial year 2025-26. In compliance with SEBI Listing Regulations, a letter is being dispatched via their Registrar and Transfer Agent (RTA), KFin Technologies Limited, to members without registered email addresses. This letter provides a weblink to access the AGM notice and the full Annual Report on the company's website. The AGM is scheduled for Tuesday, September 29, 2026, at 11:00 a.m. via Video Conferencing. Shareholders are encouraged to register or update their email addresses for seamless future communication.

Manipal Health Enterprises Ltd has announced its 16th Annual General Meeting (AGM) scheduled for September 29, 2026, to be conducted via Video Conferencing (VC)/ Other Audio- Visual Means (OAVM). The company will present its Annual Report for the financial year 2025-26, along with auditors' and board of directors' reports. Key agenda items include the adoption of standalone and consolidated financial statements for FY26, and the re-appointment of Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia as directors retiring by rotation. The company is also proposing the appointment of M/s. Price Waterhouse Chartered Accountants LLP as statutory auditors. Remote e-voting facilities will be available to shareholders from September 26 to September 28, 2026.

Manipal Health Enterprises Ltd has announced its 16th Annual General Meeting (AGM) will be held on Tuesday, September 29, 2026, at 11:00 AM IST via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The company will present its Annual Report for the financial year 2025-26, along with standalone and consolidated financial statements, and auditor and board reports. Key agenda items include the adoption of financial statements, and the re-appointment of Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia as directors. The company is also appointing M/s. Price Waterhouse Chartered Accountants LLP as statutory auditors. Members will have the facility for remote e-voting from September 26 to September 28, 2026.

Manipal Health Enterprises Ltd has filed disclosures regarding encumbrances on promoter holdings, as per SEBI (SAST) Regulations, 2011. These encumbrances are linked to covenants within certain financing documents. The disclosures were made by various promoter and promoter group entities, including Manipal Global Health Services, MEMG International Ltd, Cypress Holdings, Manipal Research & Management Services International, MEMG International India Private Limited, Dr. Ranjan Ramdas Pai, and Manipal Education and Medical Group India Private Limited. The filings indicate that these encumbrances are related to financing arrangements and do not appear to be a sale or transfer of shares, but rather security provided under loan agreements.

Manipal Health Enterprises Ltd has filed a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, concerning encumbrances on shares. These encumbrances are related to covenants in certain financing documents. The disclosure was made on September 03, 2026, by promoters and promoter group entities including Manipal Global Health Services, MEMG International Ltd, Cypress Holdings, Manipal Research & Management Services International, MEMG International India Private Limited, Dr. Ranjan Ramdas Pai, and Manipal Education and Medical Group India Private Limited. The filing indicates that these encumbrances are in place as of September 03, 2026, and pertain to specific financing arrangements.

Manipal Health Enterprises Ltd's Board of Directors convened on August 20, 2026, approving unaudited financial results for Q1 FY27 with an unmodified auditor's report. The board also appointed M/s Price Waterhouse Chartered Accountants LLP as statutory auditors for a five-year term starting from the 2026 AGM. Additionally, Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia were re-appointed as Directors, subject to member approval. The company will hold its 16th AGM on September 29, 2026, via VC/OAVM. The board also noted the payment of an upside share amount by TPG SG Magazine Pte. Ltd. to a promoter group entity.

Manipal Health Enterprises Ltd announced the appointment of M/s Price Waterhouse Chartered Accountants LLP as its Statutory Auditors for a term of five years, from the conclusion of the 16th AGM in 2026 until the 21st AGM in 2031. This appointment is subject to shareholder approval. The Board also approved the unaudited financial results for Q1 FY27 with an unmodified opinion from the outgoing auditors. Additionally, the re-appointment of two directors, Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia, and amendments to the Articles of Association were approved. The 16th AGM is scheduled for September 29, 2026.

Manipal Health Enterprises Ltd. announced that its Board of Directors, in a meeting held on August 20, 2026, approved the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27), both standalone and consolidated, along with the Limited Review Report. The Board also appointed M/s Price Waterhouse Chartered Accountants LLP as the Statutory Auditors for a five-year term starting from the 2026 AGM until the 2031 AGM. Additionally, the re-appointment of Directors Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia was approved, subject to member approval. The Articles of Association will be amended regarding director nomination rights, and the 16th Annual General Meeting is scheduled for September 29, 2026. The Board also noted the payment of upside share amount by TPG SG Magazine Pte. Ltd. to Manipal Research & Management Services International.